BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25409322)

  • 1. Phonatory dysfunction as a preclinical symptom of Huntington disease.
    Rusz J; Saft C; Schlegel U; Hoffman R; Skodda S
    PLoS One; 2014; 9(11):e113412. PubMed ID: 25409322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective acoustic quantification of phonatory dysfunction in Huntington's disease.
    Rusz J; Klempíř J; Baborová E; Tykalová T; Majerová V; Cmejla R; Růžička E; Roth J
    PLoS One; 2013; 8(6):e65881. PubMed ID: 23762447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice in Friedreich Ataxia.
    Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
    J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech biomarkers in Huntington's disease: A cross-sectional study in pre-symptomatic, prodromal and early manifest stages.
    Kouba T; Frank W; Tykalova T; Mühlbäck A; Klempíř J; Lindenberg KS; Landwehrmeyer GB; Rusz J
    Eur J Neurol; 2023 May; 30(5):1262-1271. PubMed ID: 36732902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report in changes in phonatory physiology following voice therapy: application of high-speed imaging.
    Patel RR; Pickering J; Stemple J; Donohue KD
    J Voice; 2012 Nov; 26(6):734-41. PubMed ID: 22717492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phonatory function after prolonged voice use in Brazilian woman.
    Pellicani AD; Ricz HM; Ricz LN
    Codas; 2015; 27(4):392-9. PubMed ID: 26398264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Determinants of Dual Tasking in People With Premanifest Huntington Disease.
    Reyes A; Bartlett DM; Rankin TJ; Zaenker P; Turner K; Teo WP; Fu SC; Domingos J; Georgiou-Karistianis N; Ziman M; Cruickshank TM
    Phys Ther; 2021 Apr; 101(4):. PubMed ID: 33482001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the relationship between spectral and cepstral measures of voice and the Voice Handicap Index (VHI).
    Awan SN; Roy N; Cohen SM
    J Voice; 2014 Jul; 28(4):430-9. PubMed ID: 24698884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal somatosensory deficits in Parkinson's disease: implications for speech respiratory and phonatory control.
    Hammer MJ; Barlow SM
    Exp Brain Res; 2010 Mar; 201(3):401-9. PubMed ID: 20012947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical thickness, stance control, and arithmetic skill: An exploratory study in premanifest Huntington disease.
    Nanetti L; Contarino VE; Castaldo A; Sarro L; Bachoud-Levi AC; Giavazzi M; Frittoli S; Ciammola A; Rizzo E; Gellera C; Bruzzone MG; Taroni F; Grisoli M; Mariotti C
    Parkinsonism Relat Disord; 2018 Jun; 51():17-23. PubMed ID: 29496355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic and Perceptual Analyses of Adductor Spasmodic Dysphonia in Mandarin-speaking Chinese.
    Chen Z; Li J; Ren Q; Ge P
    J Voice; 2019 May; 33(3):333-339. PubMed ID: 29449062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia using phonatory break analysis.
    Roy N; Whitchurch M; Merrill RM; Houtz D; Smith ME
    Laryngoscope; 2008 Dec; 118(12):2245-53. PubMed ID: 19029863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Parkinson Disease Tremor Phenotype on Cepstral Peak Prominence and Transglottal Airflow in Vowels and Speech.
    Burk BR; Watts CR
    J Voice; 2019 Jul; 33(4):580.e11-580.e19. PubMed ID: 29472149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in adductor spasmodic dysphonia: acoustic evidence.
    Sapienza CM; Murry T; Brown WS
    J Voice; 1998 Jun; 12(2):214-22. PubMed ID: 9649077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voice tremor: what we know and what we do not know.
    Gillivan-Murphy P; Miller N
    Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):155-9. PubMed ID: 21460728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term phonatory function following acoustic neuroma surgery: a cohort study.
    Abbas-Kayano RT; Solla D; Rabelo NN; Gomes M; Cabrera H; Teixeira MJ; Figueiredo EG
    Acta Otolaryngol; 2020 Aug; 140(8):646-650. PubMed ID: 32347145
    [No Abstract]   [Full Text] [Related]  

  • 20. Is insufficient pulmonary air support the cause of dysphonia in chronic obstructive pulmonary disease?
    Hassan MM; Hussein MT; Emam AM; Rashad UM; Rezk I; Awad AH
    Auris Nasus Larynx; 2018 Aug; 45(4):807-814. PubMed ID: 29325856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.